STML

Stemline Therapeutics, Inc. News Headlines

$15.68
*  
0.12
 negative 
0.76%
Get STML Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    STML Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Stemline Therapeutics To Present At Needham Conference ; Webcast At 12:10 PM ET
4/8/2014 11:10:00 AM - RTT News

FDA OKs Stemline Therapeutics' IND Application For SL-701 - Quick Facts
4/8/2014 7:29:00 AM - RTT News

Steven Cohen Tops GuruFocus' Real Time Picks of the Week
4/4/2014 7:02:11 PM - GuruFocus

Stemline Therapeutics To Present At RBC Conference; Webcast At 4:05 PM ET
2/26/2014 3:00:00 PM - RTT News

Stemline Therapeutics (STML) Worth Watching: Stock Rises 8.1% - Tale of the Tape
2/24/2014 10:25:01 AM - Zacks.com

Stemline Therapeutics (STML) Soars: Stock Up 17.5% - Tale of the Tape
2/12/2014 9:51:01 AM - Zacks.com

Ram Selvaraju: A Pair Of Companies Ride The Sea Change In Cancer Therapeutics
2/7/2014 2:22:00 PM - Seeking Alpha

Stemline Therapeutics (STML) Soars: Stock Up 39.5% - Tale of the Tape
1/21/2014 10:39:01 AM - Zacks.com

Reasons To Sell Immuno And Buy Northwest
12/19/2013 2:03:00 PM - Seeking Alpha

Recent Drop In Stemline Therapeutics Creates Buying Opportunity
10/23/2013 3:15:00 PM - Seeking Alpha

Uplisting To Nasdaq Just The Start Of Advaxis' Turnaround
10/17/2013 7:33:00 AM - Seeking Alpha

Strong Year For IPOs
9/18/2013 4:51:00 AM - Seeking Alpha

Positive Data And Investor Interest Uphold Stemline's Momentum
8/19/2013 11:06:00 AM - Seeking Alpha

Stemline: An Oncology Company, Not A Regenerative Cell Therapy Company
7/26/2013 3:47:00 PM - Seeking Alpha

Oncology Misdirection And The Man Behind The Curtain
7/25/2013 3:50:00 PM - Seeking Alpha

Raghuram 'Ram' Selvaraju On The Best Biotech Ideas Of 2013
7/22/2013 8:20:00 AM - Seeking Alpha

Stemline, Targeting Cancer Stem Cells, Presented Promising Cancer Data At ASCO
6/4/2013 9:52:00 AM - Seeking Alpha

US IPO Recap: May ends with 30 pricings, two billion-dollar deals set for June
6/2/2013 8:02:30 PM - Renaissance Capital

Post-IPO Strength Seen In Stemline Therapeutics
5/2/2013 5:43:00 PM - Seeking Alpha

Most January Pricings Since 2006, Zoetis Surges In Debut
2/5/2013 5:55:00 AM - Seeking Alpha

4 Companies Ringing The Bell
2/4/2013 4:58:00 AM - Seeking Alpha

Weekly recap: Most January pricings since 2006, Zoetis surges in debut
2/1/2013 6:13:06 PM - Renaissance Capital

Biotech Stemline Therapeutics prices upsized IPO at $10, the low end of the range
1/28/2013 10:09:48 PM - Renaissance Capital

5 IPOs Planned For This Week
1/28/2013 4:07:00 PM - Seeking Alpha

5 IPOs Scheduled For The Week Of Jan. 28
1/28/2013 12:18:00 PM - Seeking Alpha